Investigators are studying whether the combined triple-agonist effect on appetite, energy expenditure, and hepatic lipid handling translates to reductions in liver fat content
Be good to yourself
In brief, serial dilutions of G49 and Fc-GLP1 in assay buffer (as above) were added in duplicate to CHO cells recombinantly expressing human GLP-1R and incubated for 30 min at RT before detection with the cAMP dynamic 2 HTRF assay
Metabolite concentrations below the limit of detection were recorded as zero values, and results were normalised to creatinine concentrations (determined using the ChromSystems MassChrom Amino Acid Analysis kit), expressed as mol/mmol/creatinine
In response to our concerns, the applicant commented that it is committed to providing the clinical evidence necessary to satisfy the substantial clinical improvement standard and indicated that it is currently conducting an ongoing prospective, multicenter, open-label, single-arm clinical study [44] to evaluate the Axoguard HA+ Nerve Protector TM in patients undergoing a first revision cubital tunnel decompression procedure for recurrent or recalcitrant cubital tunnel syndrome
